Sigma Healthcare (ASX:SIG) Interest Expense: A$-44 Mil (TTM As of Dec. 2025)

What is Sigma Healthcare Interest Expense?

Sigma Healthcare ASX:SIG +2.20% 59 Interest Expense is A$-44 Mil as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 59/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Sigma Healthcare's interest expense for the six months ended in Dec. 2025 was A$ -28 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$-44 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Sigma Healthcare's Operating Income for the six months ended in Dec. 2025 was A$ 281 Mil. Sigma Healthcare's Interest Expense for the six months ended in Dec. 2025 was A$ -28 Mil. Sigma Healthcare's Interest Coverage for the quarter that ended in Dec. 2025 was 10.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sigma Healthcare (ASX:SIG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Sigma Healthcare's Interest Expense for the six months ended in Dec. 2025 was A$-28 Mil. Its Operating Income for the six months ended in Dec. 2025 was A$281 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was A$1,802 Mil.

Sigma Healthcare's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2025 )	/	Interest Expense (Q: Dec. 2025 )
	=	-1	*	281.042	/	-27.677
	=	10.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Sigma Healthcare Interest Expense Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Interest Expense can be seen below:

Sigma Healthcare Interest Expense Chart

Sigma Healthcare Annual Data

Trend

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Jan25

Interest Expense

Get a 7-Day Free Trial

-11.83

-10.84

-14.41

-16.30

-18.51

Sigma Healthcare Semi-Annual Data
	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24	Jul24	Jan25	Dec25
Interest Expense	Get a 7-Day Free Trial															-5.51	-10.79	-2.51	-16.01	-27.68

59GF Score

Sigma Healthcare Ltd ASX:SIG

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sigma Healthcare Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-44 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of A$-44 Mil mean?

Sigma Healthcare (ASX:SIG) has a Interest Expense of A$-44 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sigma Healthcare and its competitors.

Is Sigma Healthcare's Interest Expense too high?

Sigma Healthcare's current Interest Expense is A$-44 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Sigma Healthcare's Interest Expense compare to MCK and CAH?

Sigma Healthcare's Interest Expense of A$-44 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Distribution company?

A good Interest Expense depends on the Medical Distribution industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Sigma Healthcare and its competitors. Sigma Healthcare's current Interest Expense is A$-44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sigma Healthcare stock overvalued right now?

Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.79 — trading 654.1% above its estimated fair value. The current Interest Expense is A$-44 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Interest Expense is A$-44 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.79 is trading 654.1% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

Interest Expense: A$-44 Mil
GF Value™: A$0.37 vs. price of A$2.79 (654.1% above fair value)
GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Industry Healthcare Medical Distribution

Comparable Companies ASX:PGC ASX:MYX ASX:CYC MCK CAH COR HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP SHSE:600511 IST:SELEC NZSE:EBO TSE:2784 SHSE:600739

Address 6 Albert Street, Preston, VIC, AUS, 3072

Website https://www.sigmahealthcare.com.au

Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.

59GF Score

Get the complete analysis for ASX:SIG

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.79

Price

A$0.37

GF Value

View ASX:SIG Analysis

See Interest Expense data for all stocks →